Welcome to our dedicated page for Surgery Partners news (Ticker: SGRY), a resource for investors and traders seeking the latest updates and insights on Surgery Partners stock.
Surgery Partners, Inc. (NASDAQ: SGRY) is a healthcare services company headquartered in Brentwood, Tennessee, focused on short-stay and outpatient surgical care. News about Surgery Partners often centers on its performance as a short-stay surgical facility owner and operator, its financing activities, and developments across its network of ambulatory surgery centers, surgical hospitals, multi-specialty physician practices and urgent care facilities.
Investors following SGRY news can expect regular quarterly earnings announcements that discuss revenue growth, same-facility revenues, case volumes, Adjusted EBITDA and liquidity. These releases frequently include guidance ranges for full-year revenues and Adjusted EBITDA, along with commentary from management on operational execution, portfolio performance and the company’s long-term growth approach.
In addition to earnings, Surgery Partners’ news flow includes updates on capital structure and debt financing. Recent items have described the issuance and pricing of 7.250% senior unsecured notes due 2032 through its subsidiary, Surgery Center Holdings, Inc., as well as amendments to its credit agreement that introduce refinancing term loans and revolving credit commitments. These developments are relevant for understanding the company’s funding strategy and leverage profile.
Strategic and partnership news is another key theme. For example, Surgery Partners has announced a joint venture with Baylor Scott & White Health to jointly own a 16-bed hospital in Bryan, Texas, known as The Physicians Centre Hospital. This facility offers a broad range of surgical services, including bariatric, orthopedic, ophthalmologic, gastroenterological, podiatric, spinal and urologic procedures, along with general, plastic and reconstructive surgery, sports medicine, pain management and radiology services.
Governance and leadership updates, such as changes in board roles, executive appointments and resignations, are also disclosed through news releases and Form 8-K filings. For ongoing insight into SGRY, this news page aggregates company-issued announcements, financial updates and material events reported to the SEC.
Surgery Partners (NASDAQ:SGRY) will release first quarter 2026 results before the market opens on Tuesday, May 5, 2026, followed by a conference call at 8:30 a.m. ET. Live dial-in numbers, replay details and a webcast on the company's Investor Relations website are provided.
The replay will be available until May 19, 2026, and the company posts financial and material information on its website.
Surgery Partners (NASDAQ:SGRY) appointed Lloyd Dean to its Board of Directors on March 12, 2026. Mr. Dean is a former CEO of CommonSpirit Health and Dignity Health, a healthcare adviser to federal administrations, and currently serves on multiple corporate boards and as a Bain Capital senior advisor.
This addition brings national health system leadership experience aimed at supporting Surgery Partners' expansion of high‑value outpatient surgical care.
Ortelius Advisors delivered an open letter to Surgery Partners (NASDAQ: SGRY) stockholders on March 10, 2026, criticizing management and the board for poor performance and value destruction.
Ortelius cites a 67% five-year stock decline and proposes monetizing surgical hospitals to generate billions, repurchase shares, reduce debt, refresh the board, and refocus on ambulatory surgery centers to unlock intrinsic value.
Surgery Partners (NASDAQ:SGRY) will present at the Barclays 28th Annual Global Healthcare Conference on Tuesday, March 10, 2026 at 2:30 p.m. ET.
Interested parties can listen via a simultaneous webcast through the company's investor relations website at www.surgerypartners.com. A replay will be available for a limited time.
Surgery Partners (NASDAQ: SGRY) acquired Preferred Vascular Group, an ambulatory surgical center operator focused on dialysis access procedures. PVG operates eight ASCs in Georgia and Ohio with 16 physicians and >160 employees. The deal gives Surgery Partners entry into the $6 billion dialysis access market with over two million procedures annually and retains PVG management to run the new operating entity.
Ziegler served as exclusive financial advisor to PVG; legal counsel included Benesch for PVG and McDermott for Surgery Partners.
Surgery Partners (NASDAQ:SGRY) reported fourth-quarter and full-year 2025 results and set 2026 guidance, while announcing a new share repurchase program. Full-year revenue rose to $3.3 billion (+6.2%) and Adjusted EBITDA reached $526.2 million (+3.5%).
The company posted a full-year net loss attributable to Surgery Partners of $77.9 million, finished the year with $239.9 million in cash and $692.8 million of revolver capacity, and authorized up to $200 million in share repurchases. 2026 guidance targets Adjusted EBITDA of at least $530 million and revenue of $3.35–3.45 billion (ex-M&A).
Surgery Partners (NASDAQ:SGRY) will release Q4 2025 results after market close on Monday, March 2, 2026, followed by a conference call on Tuesday, March 3, 2026 at 8:30 a.m. ET.
Live dial-in numbers, a webcast via the Investor Relations website, and a replay available through March 17, 2026 (passcode 13758530) were provided for investors and other parties.
Surgery Partners (NASDAQ:SGRY) priced an add-on offering of $425.0 million aggregate principal amount of 7.250% senior unsecured notes due 2032. The Issuer expects the offering to close on December 16, 2025, subject to customary closing conditions.
The Notes will be guaranteed by each domestic wholly-owned subsidiary that guarantees the Issuer’s senior secured credit facilities and will be issued as part of the same series as the $800.0 million of 7.250% senior notes due 2032 issued in April 2024. Surgery Partners intends to use net proceeds for general corporate purposes, including repaying borrowings under its revolving credit facility. The offering is being made under Rule 144A and Regulation S.
Surgery Partners (NASDAQ:SGRY) announced that subsidiary Surgery Center Holdings intends to offer an additional $425.0 million aggregate principal amount of its 7.250% senior unsecured notes due 2032, to be issued as part of the same series as the April 2024 notes.
The Notes will be guaranteed on a senior unsecured basis by each domestic wholly owned subsidiary that guarantees the issuer’s senior secured credit facilities. Net proceeds are intended for general corporate purposes, including possible repayment of outstanding borrowings under the company’s revolving credit facility. The offering will be limited to qualified institutional buyers (Rule 144A) in the U.S. and non-U.S. persons under Regulation S, and the Notes will not be registered under the Securities Act.
Surgery Partners (NASDAQ:SGRY) and Baylor Scott & White Health formed a joint venture announced Dec 08, 2025 to jointly own the 16-bed Physicians Centre Hospital in Bryan, Texas.
The hospital will operate under the Baylor Scott & White name while Surgery Partners will continue day-to-day management. Patients can keep current providers. Services include bariatric, ophthalmologic, oral/maxillofacial, orthopedic, GI, podiatric, spinal, urologic, general, plastic/reconstructive surgery, sports medicine, pain management and radiology.